Research Chemical Designation & Liability

Compounds indexed in the MinMaxMuscle archive are strictly for laboratory research and development. They are NOT approved for human consumption. Theoretical dosing data is aggregated from clinical literature and must not be construed as medical instruction. Professional medical consultation is mandatory prior to any research application.

Full Disclaimer
Archive Identifier

Hexarelin

Growth Hormone Secretagogues

Molecular Dossier

  • Rank Index: 37
  • Status: Research Only
  • What does this mean?
  • Molecular Structure: C47H58N12O6 (His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2)

About Hexarelin

Synthetic hexapeptide growth hormone secretagogue (GHS) that mimics ghrelin to stimulate potent pulsatile release of endogenous growth hormone.

Clinical Focus

Pulsatile GH Release

Archival Aliases

HEX, The Pulsatile GHRP

Frequently Asked Questions

What are the strict legal and safety limitations for research-grade peptides?

All products listed in this research database are intended solely for laboratory research purposes and are not for human or animal consumption, diagnostic, or therapeutic use. As a researcher, it is your responsibility to ensure that all experimental protocols comply with local and federal regulations. These compounds are provided in lyophilized form to maintain chemical stability and must be handled by qualified professionals in a controlled environment. Any use outside of a supervised laboratory setting is strictly prohibited and violates the intended research application of these materials.

What are the potential risks of improper peptide handling in a research environment?

Improper handling of peptides can lead to rapid degradation, loss of potency, or chemical contamination. Exposure to high temperatures, direct sunlight, or physical agitation (shaking the vial) can break the delicate peptide bonds, rendering the research sample useless for data collection. Furthermore, using non-sterile solvents or failing to maintain a cold chain during transport can introduce bacterial pathogens. Researchers must prioritize aseptic techniques and precise reconstituting protocols to ensure the integrity of the experimental results and the longevity of the research material.

Clinical Data Matrix

Parameter Clinical Value
Molecular Weight C47H58N12O6 (His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2)
Primary Pathway Growth Hormone Secretagogues
Research Phase Research Only

Clinical Pros

  • Highly selective receptor modulation
  • Documented efficacy in Phase II trials
  • Minimal systemic cross-reactivity

Research Limitations

  • Limited long-term human data
  • Strict storage and reconstitution requirements
  • Potential for acute homeostatic feedback loops

Community Discussion

Share your questions and experiences with other researchers in the forum.

Discuss in Forum

Clinical Reference Nodes

[REF 1] pubmed.ncbi.nlm.nih.gov

Data Verified: 2026-04-10

Synergistic Matrix